Can Fite Biopharma
CANF
#10540
Rank
NZ$12.62 M
Marketcap
NZ$5.89
Share price
1.18%
Change (1 day)
227.54%
Change (1 year)

Annual Reports (20-F)

Latest form 20-F annual reports for Can Fite Biopharma CIK: 0001536196
The 20-F is a 10-K equivalent for non-US companies, as a foreight company Can Fite Biopharma only files 20-F reports

Thumbnail Can Fite Biopharma
 20-F Annual Report

20-F Annual Report 2026-03-26

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report

20-F Annual Report 2025-04-14

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report

20-F Annual Report 2024-03-28

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report

20-F Annual Report 2023-03-30

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report

20-F Annual Report 2022-03-24

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report

20-F Annual Report 2021-03-25

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report

20-F Annual Report 2020-03-27

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report

20-F Annual Report 2019-03-29

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report

20-F Annual Report 2018-03-28

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report

20-F Annual Report 2017-03-30

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report

20-F Annual Report 2016-03-31

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report

20-F Annual Report 2015-03-27

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report

20-F Annual Report 2014-03-31

Language: English

View Annual Report (20-F)